Checkpoint Therapeutics, Inc.
CKPTDelisted May 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651407
Checkpoint Therapeutics, Inc. was delisted on May 30, 2025; its insiders filed their last Form 4 on Jun 3, 2025; 84 institutions reported holding it in 13F filings for Q1 2025, worth $137.7M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Checkpoint Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 35 | 39 | +4 |
| Shares | 2.67M | 3.93M | +1.26M (+47.3%) |
| Value | $6.51M | $6.68M | +$161.6K (+2.5%) |
New holders (9)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sabby Management, LLC | 205,247 | $348.9K | 1.10% |
| Park Avenue Securities LLC | 59,932 | $102.0K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 47,750 | $81.2K | 0.00% |
| Millennium Management LLC | 21,339 | $36.3K | 0.00% |
| XTX Topco Ltd | 20,941 | $35.6K | 0.01% |
| Ethos Financial Group, LLC | 12,060 | $20.5K | 0.01% |
| Tower Research Capital LLC (TRC) | 5,799 | $9.86K | 0.00% |
| Simplex Trading, LLC | 2,152 | $3.00K | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 300 | $510 | 0.00% |
Sold out (5)
Institutions that held Checkpoint Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jump Financial, LLC | 16,500 | $40.8K |
| Cubist Systematic Strategies, LLC | 14,488 | $35.8K |
| Group One Trading, L.P. | 3,719 | $9.19K |
| Nemes Rush Group LLC | 2,075 | $5.13K |
| Meitav Dash Investments Ltd | 28,970 | – |